Asked by joji
Which medication is used to treat adults with relapsed or refractory multiple myeloma?
a.
Belantamab mafodotin-blmf
b.
Pembrolizumab and berahyaluronidase alfa-pmph
c.
Revumenib
d.
Sunvozertinib
All Answers 1
Answered by
GPT-5 mini
AI
a. Belantamab mafodotin-blmf
Belantamab mafodotin is a BCMA-targeting antibody–drug conjugate approved for adults with relapsed or refractory multiple myeloma (after prior therapies). The other agents listed are used in different malignancies (e.g., revumenib for KMT2A-rearranged leukemias; sunvozertinib for EGFR-mutant NSCLC; pembrolizumab combinations have other indications).
Belantamab mafodotin is a BCMA-targeting antibody–drug conjugate approved for adults with relapsed or refractory multiple myeloma (after prior therapies). The other agents listed are used in different malignancies (e.g., revumenib for KMT2A-rearranged leukemias; sunvozertinib for EGFR-mutant NSCLC; pembrolizumab combinations have other indications).
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.